MDWD / MediWound to Present at Upcoming Investor Conferences in February

MediWound (MDWD) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisio more_horizontal

YAVNE, Israel, Sept. 05, 2023 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully integrated biopharmaceutical company focused on next-generati more_horizontal

MediWound (MDWD) came out with quarterly earnings of $0.10 per share, beating the Zacks Consensus Estimate of a loss of $0.41 per share. This compares more_horizontal

MediWound, a company developing medical solutions for skin and burn conditions, is set to begin US distribution of its burn solution NexoBrid in Q3 20 more_horizontal

MediWound (MDWD) came out with a quarterly loss of $0.44 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to loss of $0 more_horizontal

MediWound Ltd. (NASDAQ:MDWD ) Q4 2022 Earnings Conference Call March 16, 2023 8:30 AM ET Company Participants Monique Kosse - LifeSci Advisors, IR Ofe more_horizontal

MediWound (MDWD) delivered earnings and revenue surprises of -521.05% and 56.79%, respectively, for the quarter ended December 2022. Do the numbers ho more_horizontal

Conference Call and Webcast Scheduled for Thursday, March 16 at 8:30 am Eastern Time Conference Call and Webcast Scheduled for Thursday, March 16 at 8 more_horizontal